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Abstract
Objective: The combination of anorganic bovine bone (ABB) with platelet-rich
plasma (PRP) has been widely used in bone regeneration procedures although its
benefits are still unclear. The purpose of this study was to evaluate whether or not PRP
improves the efficacy of ABB in sinus floor augmentation. In addition, we have
investigated the effect of residual bone height and tobacco on implant survival in sinus
augmentation procedures.
Pateint and Methods: Eighty-seven patients recruited for this study underwent 144
sinus floor augmentation procedures using ABB alone or ABB plus PRP (ABB1PRP)
in a randomized clinical trial. A total of 286 implants were placed in the augmented
bone, and their evolution was followed up for a period of 24 months. In order to
investigate on a histological level and any adjunctive effects, we performed an
ancillary study in five edentulous patients with a symmetrical severely resorbed
maxilla. In these patients, a bilateral sinus augmentation was randomly performed
using ABB or ABB1PRP in a split-mouth design, and after 6 months, bone biopsies
were taken from the implant sites for histological and histomorphometric analysis.
Results: Overall, 96.2% of ABB and 98.6% of ABB1PRP implant success were
obtained during the monitoring period and differences were not found between sites
grafted with and without PRP in the 87 patients studied. Densitometry assessments and
graft resorption were similar in both experimental groups. However, the histological
and histomorphometrical analysis in the five edentulous patients revealed that bone
augmentation was significantly higher in sites treated with ABB1PRP (p40.05).
Another outcome from our study is that the lack of initial bone support (p40.05) and
smoking (p5 0.05) appeared to have a negative effect on the treatment success, which
was accentuated when both circumstances coincided.
Conclusions: PRP is not a determining factor for implant survival in sinus lifting
procedures. However, this study revealed that PRP can improve the osteoconductive
properties of ABB by increasing the volume of new bone formed. Moreover, in sinus
augmentation procedures the implant’s survival rate appears to be more influenced by
the residual bone height or by tobacco than by the type of bone graft.
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Dental implants’ reconstruction of eden-
tulous jaws with adequate bone volume
and density has achieved a high level
of reliability and a considerable rate of
success (Adell et al. 1990). However, the
quality of bone in the posterior maxillary
regions often shows a low level of miner-
alization (type IV), and severe bone
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resorption, two factors that render the
initial stability ofQ2 dental implants difficult
(Mish 1990, McCarthy et al. 2003).
Besides, the volume of bone in this area
is usually limited by the maxillary sinus
pneumatization, hindering implant place-
mentQ3 (Bra˚nemark et al. 1984, Blomqvist
et al. 1996).
The maxillary sinus-lift surgical tech-
nique increases the bone height in the
posterior area, and enables the place-
ment of implant-supported prostheses
(Tatum 1986). This procedure involves
the detachment of Shneider’s membrane
from the maxillary sinus floor, creating a
space that is filled with a grafting mate-
rial to promote a vertical bone augmen-
tation into the maxillary sinus cavity.
Different grafting materials have
been used to fill the space created
between the superiorly repositioned
sinus membrane and the floor of the
maxillary sinus. Early studies advocated
the use of autogenous bone in the aug-
mented space (Boyne & James 1980).
However, its availability is restricted by
the limited amount of intra-oral grafts,
the morbidity associated with the second
surgery at the donor site and the high
cost for bone harvesting from extra-oral
sites. Therefore, alternative graft mate-
rials have been developed, including
demineralized (human) bone matrix
(Groeneveld et al. 1999) anorganic
bovine boneQ4 (ABB) (Valentini & Aben-
sur 2003), tricalcium phosphate (Zijder-
veld et al. 2005) or bioactive glass
particles (Tadjoedin et al. 2000).
Bio-Osss (Geistlich BiomaterialsQ5 ) is a
biocompatible and osteoconductive (Ben-
ezra et al. 2002Q6 ) ABB that provides an
ideal scaffold for new bone formation
Q7 (Ha¨merle et al. 1998, Piattelli et al.
1999). It hasQ8 been extensively used in
maxillary sinus floor augmentation
(Valentini & Abensur 2003, Wallace et
al. 2005) with high clinical success rates
(Carmagnola et al. 2003). However, the
lack of osteo-inductive properties encour-
aged researchers to find ways of improv-
ing its performance in vivo, and the
addition of platelet-rich plasma (PRP)
has been assayed. PRP is an autologous
fibrin adhesive with a high platelet con-
centration easily obtained from whole
blood by centrifugationQ9 (Antonaides
1981, Marx et al. 1998, Anitua 1999).
Furthermore, PRP has a high concentra-
tion of angiogenic and mitogenic growth
factors implicated in bone healing, such as
transforming growth factor (TGF)
(Wikesjo¨ et al. 1998)Q10 , platelet-derived
growth factor (PDGF) and insulin-like
growth factor (Giannobile et al. 1996),
and has been used in sinus floor elevation
recentlyQ11 (Philippart et al. 2005, Consolo
et al. 2007, Galindo-Moreno et al. 2007).
NeverthelessQ12 , preliminary case reports
using PRP as an adjuvant in bone regen-
eration procedures have been controver-
sialQ13 (Anitua 1999, Rolda´n et al. 2004,
Wiltfang et al. 2004, Kassolis & Reynolds
2005, Philippart et al. 2005, Klongnoi
et al. 2006a, b, Consolo et al. 2007, Galin-
do-Moreno et al. 2007) and noQ14 definitive
conclusions have been drawnQ15 from them.
The ultimate procedure for evaluating
the clinical advantages of a biomaterial
is a controlled clinical trial. However,
very few controlled clinical trials have
been performed to evaluate the use-
fulness of combining PRP with
osteoconductive materials for bone aug-
mentation procedures. The aim of this
study was to evaluate the effect of differ-
ent variables such as a combination of
PRP with ABB, residual bone height and
smoking on bone augmentation in sinus
lift procedures. For this, two randomized-
controlled clinical trials were carried out:
an inter-patient clinical trial in a group of
87 patients and a split-mouth clinical trial
conducted in a group of five patients. The
control group consisted of maxillary sinus
lifting with Bio-Osss alone while the
experimental group included sinus lifting
with Bio-Osss1PRP. The results were
obtained by means of clinical investiga-
tion, radiographs, histologic and histo-
morphometric analysis.
Patient and Methods
Patients
Inter-patient randomized-controlled
clinical trial
Patients were enrolled in the study on
the basis of having insufficient bone
height (o7mm) in the posterior maxilla.
In these patients, sinus floor augmenta-
tion was planned to allow rehabilitation
with fixed implant-supported prosthesis.
Smokers were included in the study,
while patients with severe systemic
disease [American Society of Anaesthe-
siology (ASA) III or IV] and a previous
history of chronic sinusitis were
excluded. Informed written consent to
participate in this study was obtained
from all patients, in particular explain-
ing the objectives and protocol of the
study, and possible side effects. Before
commencing this study, approval was
obtained from the ethical committee for
clinical trials of the ‘‘Hospital San Car-
los’’ (Madrid, Spain), to carry out a pilot
clinical study in the dental clinic ‘‘Clin-
ica Dental Alcala’’ (Madrid, Spain).
During the study period (2003–2008),
209 patients attended ‘‘Clinica Dental
Alcala’’ demanding implant treatment.
Among these patients, 87 were recruited
for this randomized-controlled clinical
trial on the basis of having o7mm of
residual ridge in the posterior maxilla.
Patients with residual bone height
o4mm received a two-stage approach
while patients with residual bone height
! 4mm received a one-stage approach
(Zinner & Small 1996, Jensen et al.
1998). A total of 144 sinus floor aug-
mentations were performed (Fig. 1).
There was heterogeneity in the systemic
diseases present in some of the selected
patients, such as diabetes, heart failure
and osteoporosis; however, none of
these conditions are known to jeopar-
dize the implant’s success (Mombelli &
Cionca 2006). On the other hand, there
are several authors who associate smok-
ing with dental implant Q17failure (Bain &
Moy Q161993, De Bruyn & Collaert 1994,
Gorman et al. 1994, Wallace 2000,
Chuang et al. 2002), which led us to
consider Q18this variable and to evaluate its
effects on implant survival in sinus
augmentation procedures. Patients who
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reported smoking 4ten cigarettes/day
were defined as smokers (Tonetti et al.
1995), while patients who reported
smoking only occasionally were not
considered to be smokers.
Split-mouth randomized-controlled
clinical trial
In addition to the above-mentioned cri-
teria, the inclusion criteria for the split-
mouth study were patients with bilateral
loss of teeth in the maxillary premolar
and molar areas, and Cadwood classifi-
cation VQ19 or VI (Cawood & Howell
1991) that required a bilateral, two-
stage, sinus floor-lifting procedure (first
stage, bone grafting; second stage, pla-
cement of implants) (Boyne & James
1980).
Radiography (orthopantomography)
and computed tomography (CT) were
performed 6 months post-operatively on
surgical sites, before and after treatment,
and the bone density was quantified
in both PRP1ABB and ABB groups
using SIMPlant 7 (Columbia Scientific,
Columbia, MD, USA) software. Six
selected zones in each maxillary sinus
were chosen for a standardized evalua-
tion (Rao & Alfidi 1981). All five
patients were edentulous for 7–10 years
in the maxilla, which had insufficient
retention for their upper denture with a
residual alveolar ridge between 1 and
3mm diagnosed by CT (see Fig. 2).
Randomization
The allocation of participants to inter-
vention groups in a truly unpredictable,
randomized sequence was performed by
a computerized random number gener-
ated using GraphPadQuickCalc software
(GraphPad Software Inc., La Joya, CA,
USA), including the concealment of the
allocation schedule until the assignment
was made. Subject numbers were
assigned at the baseline examination in
consecutive order by the principal inves-
tigator. The sample size used has been
usual in pervious studies for this type of
clinical evaluation. Patients included in
the inter-patient clinical trial were allo-
cated by a blinded assistant into two
groups: the first was to be treated with
ABB alone, and the second with
ABB1PRP. On the other hand, each of
the patients included in the split-mouth
study was treated with ABB alone in the
maxilla of one side and with ABB1PRP
in the contralateral one. The graft mate-
rials were randomly allocated for either
side in each patient.
Blinding
The surgeon was blinded to the graft
material applied to each patient before
graft implantation. An assistant handled
the PRP–ABB or the ABB group after
the surgeon had already accessed the
sinus and elevated the membrane. The
histologist was blinded to the samples’
groups throughout the histomorphome-
trical analysis.
PRP
PRP was prepared according to Anitua’s
method15 (Anitua 1999). Blood was
collected from all patients 30min before
starting the surgery to ensure that the
blinding of the surgeon was maintained.
In the ABB1PRP group, between 10
and 20 cm3 of blood was withdrawn via
venous aspiration into 4.5 cm3 test tubes
and mixed with a 3.8% sodium citrate
solution at a 5/1 (v/v) ratio, achieving
anticoagulation through calcium bind-
ing. The blood was then centrifuged
using a Btis PRGF System II centrifuge
(Bti Biotechnology Institute S.L., Vitor-
ia, Spain) into three basic components:
red blood cells (RBCs), PRP and platelet-
poor plasma (PPP). Because of the dif-
ferent densities of the components,
the RBC layer forms at the bottom of
the tube, the PRP layer in the middle and
the PPP layer at the top. A pipette (Gilson
Inc., Middleton, WI, USA) was used
to separate the layers, from the less dense
to the denser. Therefore, PPP was sepa-
rated first (about 2.25 cm3), followed by
PRP (about 0.9 cm3), leaving the RBC
layer as a residual (about 2.25 cm3).
Flow cytometry (ADVIA 120, Hema-
tology system, Bayer, Leverkusen, Ger-
many) was used for platelet counting.
Platelet counts were 2.97 " 0.7-fold over
peripheral blood, confirming that the PRP
preparation technique used in this study
produced a source of highly concentrated
platelets. The average peripheral blood
platelet count was 275.000 " 58.000/ml.
Before its surgical application, PRP
(0.2ml) was activated with a 30% CaCl2
solution, and a PRP gel was obtained and
mixed with ABB (#1.5 g).
Surgical protocol
Because of the insufficient bone height
for implant stabilization, in all cases, the
sinus floor augmentation was prepared
following the method described by
Boyne & James (1980) and Tatum
(1986). The decision to place simulta-
neous or delayed implants depended on
whether or not the residual crest had
enough bone height to permit primary
implant stability (Zinner & Small 1996,
Jensen et al. 1998).
The osteotomy of the lateral wall of the
maxilla was performed under local anaes-
thesia, and the entire buccal plate was
removed before the elevation of the sinus
membrane and the implantation of the
assigned graft material. No membranes
were used to cover the lateral wall defect
after the bone substitute was placed. In the
two-stage sinus augmentation procedure,
a healing time of 6 months was allowed
before implant placement (Osseotite, Bio-
met 3i Inc., Palmbeach, FL, USA).
Post-operatively, antibiotics, anti-in-
flammatory and antiseptics were pre-
scribed, and sutures were removed 1
week after surgery. Patients were
instructed not to wear their prosthesis
for 2–3 weeks after surgery. For the next
4 months, the existing upper prosthesis
was adapted to the maxilla for aesthetics
and relined periodically with a soft
tissue conditioner. All patients were
required to follow a soft diet and no
mastication was permitted.
Histological and histomorphometric
procedures
The histological and histomorphometic
analysis was performed in the five
patients recruited for the split-mouth
randomized clinical trial. In these
patients, bone biopsies were obtained
from both treated sites. After a healing
period of 6 months, these patients were
called for implant placement and biop-
sies were retrieved from dental-implant
sites using a trephine burr (Ø5 3.0mm
$ 10.0mm in length) (see Fig. 3).
Fig. 2. Scheme of the split-mouth rando-
mized method used in the controlled clinical
trial. The upper panel shows a computed
tomography of a patient before surgery.
Randomly, one sinus was grafted with anor-
ganic bovine bone (ABB) alone and the
other sinus was grafted with ABB plus
platelet-rich plasma (lower panel).
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Subsequently, the biopsies were fixed in
10% formaldehyde (pH 7.4) and stored
at 41C. After dehydration in ascending
series of alcohol (60–100%), biopsies
were embedded in 2-hydroxy-ethyl-
methacrylate (Technovit, Leica Micro-
systems GMBH, Wetzlar, Germany),
then photopolymerized for 6 h with
ultraviolet light, 2 h with white light
and 6 h with blue light into ready-to-
cut sample blocks.
A saw microtome Exakts (Leica
Microsystems GmbH) was used to cut
200-mm-thick coronal sections from the
cylinders. Thereafter, the sections were
ground to a thickness of 40–50mm by
means of a grinder Exakts (EXAKT,
Norderstedt, Germany) to achieve better
histological visualization without risk-
ing the loss of the samples. Afterwards,
surface staining was performed with
basic fuchsine and methylene blue
(Donath & Breuner 1982). The histologi-
cal evaluation of bone neoformation was
carried out by means of optical micro-
scopy. The histomorphometric analysis
was performed using light micrographs
(at magnification $ 6) of the biopsy
slices, which were captured with a digital
camera and analysed with the histomor-
phometric software MIP-4 (Digital Image
System, Barcelona, Spain). The sections
were analysed by a single examiner
blinded to the bone graft material and
the following measurements were taken
from each sample: newly formed bone
volume (NB), soft tissue volume (ST) and
residual graft volume (RG). The measure-
ments were expressed as percentages of
the total sample volume.
NBð%Þ ¼ Newly formed bone volume
Total sample volume
$ 100
STð%Þ ¼ Soft tissue volume
Total sample volume
$ 100
RGð%Þ ¼ Residual graft volume
Total sample volume
$ 100
Statistical analysis
The distribution of the patients’ sys-
temic conditions (diabetes, smoking,
etc.) among clinical treatments’ groups
was assessed using the w2 test, in order
to evaluate comparability between
groups. Moreover, two-way analysis of
variance tests, in the univariate analysis,
were used to find any association
between patients’ (i) systemic condi-
tions and (ii) treatment on the one
hand and (i) implant survival and (ii)
patient treatment success on the other. A
multiple stepwise logistic regression
analysis was performed to assess the
joint contribution of the smoking beha-
viour and residual bone height to
implant survival. Histomorphometric
measurements of the biopsies taken
from the grafted sites were compared
within each patient using a t-test for
paired samples. For all univariate ana-
lyses, a p40.05 was chosen. A statis-
tical software package (SPSS 17.0,
SPSS, Chicago, IL, USA) was used for
the statistical analysis.
Results
Inter-patient-controlled clinical trial
This study started in January 2003 and
ended by June 2005. The group of 87
patients selected for the inter-patient
study consisted of 47 females and 40
males with an age range between 52
and 78 years (see Table 1). The presence
of systemic disorders was registered
among the study groups. The distribu-
tion of systemic disorders was balanced
among the different treatment groups
(Fig. 4).
Fig. 3. The upper panel shows a computed
tomography of the augmented sinus. The low-
er panel shows the harvesting of bone biopsies
6 months after sinus floor augmentation with a
trephine bur of 3mm diameter for histologic
and hiostomorphometric examination.
Table 1. Distribution of patients by systemic disorder into assigned treatment groups
Total number
of patients
Residual bone height Type of graft
one stage
(4–7mm)
two stage
(o4mm)
ABB1PRP ABB
Male 40(46) 24 (60%) 16 (40%) 31 (50%) 31 (50%)
Female 47(54) 31 (66%) 16 (34%) 43 (52.4%) 39 (47.6%)
Smoker 31(35) 18 (58%) 13 (42%) 22 (50%) 22 (50%)
Non-smoker 56(65) 38 (67.8%) 18 (32.2%) 51 (52%) 47 (48%)
Diabetes type I 4(4.5) 3 (75%) 1 (25%) 4 (57%) 3 (43%)
Diabetes type II 5(6) 2 (50%) 2 (50%) 4 (44.4%) 5 (55.6%)
Osteoporosis 11(12.6) 5 (45.4%) 6 (54.6%) 11 (55%) 9 (45%)
Ischaemic heart disease 7(8) 3 (43%) 4 (57%) 5 (45.4%) 6 (54.6%)
Hypertension 14(16) 8 (57.2%) 6 (42.8%) 10 (50%) 10 (50%)
Data are presented in absolute number (percentage).
Fig. 4. Distribution of patients’ demography as a function of residual bone height and type of
graft. DT I, diabetes type I; DT II, diabetes type II; OST, osteoporosis; HTA, hypertension;
and IHD, ischaemic heart disease.
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Among the study groups, 144 sinus
floor augmentations were performed to
receive a total of 286 implants (10–
13mm long). The implantation was
deferred in 57 sinuses and immediate
in 87. Table 2 summarizes the results
obtained.
Healing was uneventful in all patients
because none of them complained of
significant pain and no signs or symp-
toms of infection were reported. All
sinus-augmented sites allowed the
installation of one to three rough-sur-
faced implants (Osseotite, Biomet 3i
Inc.) with diameters between 3.75–5
and 10–13.0mm long. Radiological
images show that all implants displayed
full-bony integration (see Fig. 5). Six
months after their insertion, the implants
were uncovered and the patients were
rehabilitated with fixed bridge pros-
theses. After the 24-month follow-up
period, 98.6% of the patients treated
with PRP1ABB and 96.2% of those
treated with ABB presented implant
survival.
This table shows that therapeutic
groups were balanced on the basis of
smoking, gender, type of augmentation
and residual bone height to confirm that
randomization worked.
Surgical complications
Sinus membrane dehiscence was observed
in five cases (5.74%) and all of them were
small perforations (45mm). In the three
cases observed in the PRP1ABB group,
the dehiscence was sealed using PRP
alone whereas a collagen membrane was
used in the ABB group (Fig. 6). One
adverse result in outcome survival was
associated with sinus membrane dehis-
cence in a second-stage augmentation
procedure grafted with ABB.
Type of bone graft
The adhesive capacity of fibrin in
PRP1ABB facilitates the handling of
the graft material as compared with the
particles of ABB alone, making the
filling of the sinus cavity easier (see
Fig. 7).
Survival of grafts
Graft survival at the secondary surgery
was sufficient to allow implant place-
ment in all the patients included in the
study. However, we found that in five
cases partial loss of bone graft occurred
probably because membrane coverage
was not used (Fig. 8).
Table 2. Distribution of patients, sinuses and implants by residual maxillary bone height and
graft type
Type graft Residual bone height
one stage (4–7mm) two stage (o4mm)
PRP1ABB ABB PRP1ABB ABB
N patients
Unilateral intervention 11 9 4 3
Bilateral intervention 32 32 25 25
Total 55 32
N sinuses grafted 45 42 29 28
N implants placed implant survival (%) 174 (99.4) 112 (94.6)n
286 (97.5)
nSignificantly lower than surgical sites with higher residual bone height.
Fig. 5. Radiological images showing com-
pleted coverage of the implants into the
augmented sinus (black arrows).
Fig. 6. Dehiscence of sinus membrane suc-
cessfully covered with platelet-rich plasma.
Fig. 7. The adhesive capacity of platelet-rich plasma improves the handling of anorganic
bovine bone and facilitates the filling of the sinus cavity.
Fig. 8. Absence of membrane coverage of the buccal plate of the maxilla after filling the
cavity resulted in a residual space filled with connective tissue (white arrows) and partial loss
of bone graft (n) in some patients. However, we did not observe an excessive graft loss that
may compromise implant placement at second-stage surgery in any patient.
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Survival rates
Implant survival is defined as the
implant remaining in situ during the
entire observation period. In this study,
out of over 286 implants placed, 279
remained in situ during the entire obser-
vation period, being tested indepen-
dently for absence of mobility, and
seven failed, which yielded 97.5%
implant survival. We found differences
between the one- and two-stage surgery
groups, indicating that the residual
height could affect the survival rate.
Furthermore, six implants were lost at
sites with residual bone height o4mm,
while only one was lost at sites with
residual bone height between 4 and
7mm. This result indicates that the
amount of residual bone height signifi-
cantly influenced the implant survival
after sinus augmentation (p40.05);
however, the bone graft type seemed to
have no effect on implant survival.
Implant failure was higher before pros-
thetic loading, and in smokers (see
Table 3). Indeed, five out of the seven
failed implants occurred in four smok-
ing patients (p40.05). The details of the
implant’s failure in the inter-patient
study are given in Table 4.
Treatment success rate was defined as
the rate of patients that presented com-
plications during the observation period.
According to this definition, 92.8% of
the patients’ treatments were successful.
Moreover, treatments’ success seemed
to be higher in patients with more
residual bone height (p5 0.05), and in
non-smokers (p40.05).
Moreover, a o4mm residual bone
height and smoking had a combined
negative effect on the treatment success
rate, although these differences did not
reach statistical significance in the uni-
variate and multivariate analyses (see
Table 5).
Both the patient-based and the
implant-based statistical analysis of the
treatment groups agreed on the negative
effect that both smoking and reduced
residual bone height had on the im-
plant survival and treatment success.
Although there was no significant inter-
action between the two effects, the data
suggested that the negative effect on the
treatment success was accentuated when
both circumstances coincided.
Split-mouth-controlled clinical trial
The five patients included in the split-
mouth-controlled clinical trial received
10 sinus floor augmentations with a total
of 26 implants. A summary of the results
obtained from these patients is presented
in Table 6.
After 6 months, CT showed no sig-
nificant differences between ABB- and
PRP1ABB-treated sites (see Fig. 9). In
both cases, the augmented bone pre-
Table 3. Implant distribution, failure and survival as a function of the residual maxillary bone
height, bone substitute material and smoking behaviour
Type graft Residual bone height
one stage (4–7mm) two stage (o4mm)
PRP1
ABB
ABB implant
survival (%)
PRP1
ABB
ABB implant
survival (%)
Implants placed in smoking
patients
34 (1) 32(0) 98.4 24 (1) 20 (3) 90.9
Implants placed in non-smoking
patients
61(0) 47(0) 100 34(0) 30 (2) 96.9n
Total n implants placed 95(1) 79(0) 99.4 58(1) 50(5) 95.0
Implant survival (%) 98.9 100 99.4 98.2 90.7nn 95.0
(), number of failed implants;
nSignificantly different from smokers (p40.05);
nnImplant survival significantly lower than in sinuses treated with PRP1ABB (p40.05).
Table 4. Details of patients with failed implants in the inter-patient study
Gender Age
(years)
Surgical
stages
Bone
graft
Membrane’s
dehiscence
Smoking
behaviour
Failure implant’s
position
Time of
failure
M 67 1 PRP1ABB ND Yes 25 BL
F 65 2 ABB ND Yes 16 FYL
M 71 2 ABB D Yes 26, 27 BL
F 63 2 PRP1ABB ND Yes 17 FYL
F 75 2 ABB ND No 15, 16 BL
BL, before prosthetic loading; FYL, failure during first year of prosthetic loading; ND, no
dehiscence; D, dehiscence.
Table 5. Distribution of patients by residual maxillary bone height and smoking behaviour
Smoking Non- smoking Total
One stage (4–7mm) 19 (94.8) 36 (100) 55 (98.2)
Two stage (o4mm) 12 (75) 20 (95) 32 (87.5)nn
Total 31 (87.1)n 56 (98.2) 87 (92.8)
(), treatment success rate in %;
nSignificantly lower (p40.05) than non-smokers;
nnSignificantly lower (p40.05) than one-stage treated patients.
Table 6. Patient, implants and graft data for the split mouth clinical trial
Patient Gender Age
(years)
Preoperative
bone height
(mm)
Healing time
(months)
Postoperative
bone height
(mm)
Implants’
position
PRP1ABB ABB PRP1ABB ABB
1 M 55 2 3 6 13 13 14, 16, 25, 26
2 F 67 1 1 6 11 10 14, 15, 16
24, 26, 27
3 M 62 2 2 6 11 10 14,16,17
25, 26, 27
4 F 58 1 3 6 12 13 15,17
16, 17
5 F 64 3 2 6 14 12 15, 16, 17
25, 26, 27
6 Torres et al.
r 2009 John Wiley & Sons A/S
Journal compilation r 2009 John Wiley & Sons A/S
CPE 1437(BW
UK
 C
PE
 14
37
.PD
F 0
8-J
un
-09
 17
:54
 21
28
71
1 B
yte
s 1
1 P
AG
ES
 n 
op
era
tor
=h
v.a
na
nth
a)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
sented adequate volume for implant
placement, and both sites showed a
similar radiographic aspect. Similarly,
densitometric assessment showed no
significant differences between both
treatment modalities (see Fig. 10). The
height of the augmented bone was simi-
lar in both groups: 10.4 " 0.7 and
9.4 " 0.7mm in PRP1ABB and ABB,
respectively.
Upon histological observation, all
biopsies revealed the presence of trabe-
cular bone and remaining ABB granules
within the treated maxillary sinuses (see
Fig. 11). Differences between native
pre-existing bone and newly formed
bone were clearly observed because of
the presence of ABB particles in the
whole augmented area. On the surfaces
of ABB particles, newly formed bone
and connective tissue were present. The
growth of bone took place mainly
through the guidance of ABB particles
from the pre-existing bone surface of the
sinus floor along the augmented area,
and bridges of woven bone between the
grafted particles could be observed,
connecting them into a mass of miner-
alized tissue (see Fig. 12). We also
observed newly formed bone even in
the most apical part of the samples.
Bone formation around the grafted
bone particles (ABB) was seen in both
the PRP and the non-PRP group.
Furthermore, as shown in Fig. 13, the
resorption of ABB particles is low.
Histomorphometric analysis revealed
that the area occupied by newly formed
bone was higher in the sites treated with
PRP, while the average areas occupied
by ABB particles were almost the same
in the two groups (see Fig. 14).
Discussion
Although sinus lifting is a reliable tech-
nique for vertical bone augmentation in
the posterior maxilla, implant loss is still
registered as often as in 17% of the
patients with less than 6mm residual
bone Q20height (Tonetti & Ha¨mmerle
2008). For this reason, bioactive agents
are being tested in order to improve the
clinical outcome of these procedures
(Palmer et al. 2008).
Platelets are a natural source of
growth factors with beneficial effects
on tissue healing (Lynch et al. 1991,
Giannobile et al. 1996, Wikesjo¨ et al.
1998, Anitua et al. 2004); however, the
Q21use of PRP in bone regeneration in
humans is a moot question (Anitua
1999, Rolda´n et al. 2004, Wiltfang
et al. 2004, Kassolis & Reynolds 2005,
Philippart et al. 2005, Klongnoi et al.
2006a, b, Consolo et al. 2007, Galindo-
Moreno et al. 2007). Recent systematic
reviews of randomized-controlled clin-
ical trials combining PRP with grafting
materials still show conflicting and
inconclusive results (Palmer et al.
2008). The controversy extends to ani-
mal studies because in some of them,
significant benefits have been reported
Fig. 9. Computed tomography of the same
patient before (a) and 6 months after (b)
surgery. The right sinus was grafted with
PRP1ABB, and the left sinus was grafted
with ABB alone. ABB, anorganic bovine
bone; PRP, platelet-rich plasma.
Fig. 10. Densitometry of maxillary sinuses before treatment, and 6 months after initial
intervention in the patients included for the split-mouth clinical trial.
Fig. 11. Histological overview of biopsies
taken from the sinus of patient 2 in Table
7, showing residual bone (RB) and two
squares delimiting coronal (dark square)
and apical (white square) sites of the sample,
where new bone formation appears between
ABB particles in both groups: the one trea-
ted with ABB alone (a) and the one treated
with PRP1ABB (b). (Original magnification
$ 2.5.) ABB, anorganic bovine bone; PRP,
platelet-rich plasma.
Fig. 12. Image of patient 3 of Table 7. Bone
formation took place in the coronal part of
the biopsy in both groups (a) PRP1ABB and
(b) ABB alone. The presence of new bone
(NB) surrounding ABB particles (RG, resi-
dual graft) and creating bridges between ABB
particles can be observed in both groups.
(Original magnification $ 20.) ABB, anor-
ganic bovine bone; PRP, platelet-rich plasma.
Q29
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with the use of PRP mixed with bone
substitutes in sinusQ22 lift procedures (Kas-
solis et al. 2000, Rodriguez et al. 2003,
Mazor et al. 2004, Kassolis & Reynolds
2005), whereas other studies have not
Q23 shown any beneficial effect (Aghaloo
et al. 2002, 2005, Fu¨rst et al. 2003,
Jakse et al. 2003, Butterfield et al.
2005, Klongnoi et al. 2006a, b, Rolda´n
et al. 2008).
One possible explanation for the dis-
agreement could be attributed to the
different number of centrifugations
used for preparing PRP (one or two
centrifugations) (Marx et al. 1998, Ani-
tua 1999). The main advantage of one
centrifugation technique is the mini-
mum leucocyte count and lesser con-
centration of PDGF and TGF-b in
comparison with two centrifugation
techniques. The absence of leucocytes
is important because neutrophils are a
source of matrix metalloproteinases
(MMP-8 and -9) and secrete other pro-
teases, such as elastases that are destruc-
tive for growth factors (Anitua et al.
2008). Moreover, in the two centrifuga-
tion techniques, there are different
methods for cell separation (Weibrich
et al. 2002a, b, 2003a, b, 2004) that lead
to significant differences in the amounts
of cells (platelets and leucocytes) and
levels of growth factors in the PRP
samples (Weibrich et al. 2003a, b).
The concentration of platelets seems
to play an important role in the regen-
erative process. Thus, PRP with an
intermediate concentration of platelets
(two to sixfold from peripheral blood)
have shown beneficial effects, while
lower (0.5–1.5-folds) and higher (9–
11-folds) concentrations did not demon-
strate beneficial effects (Weibrich et al.
2004). Herein, the centrifugation tech-
nique concentrates platelets to 2.9 "
0.7-fold over peripheral blood, support-
ing a desirable effect of PRP.
After 6 months of treatment, our
results did not show significant differ-
ences between densitometric values of
the augmented areas between both
groups. Raghoebar et al. (2005) obtained
similarQ25 results although other studies
report higher densitometric values for
the PRP sites (Marx et al. 1998, Consolo
et al. 2007). However, some clinical
studies indicate the ineffectiveness of
PRP in sinus augmentation procedures
(Danesh-Meyer et al. 2001, Raghoebar
et al. 2005, Thor et al. 2007, 2005, Schaaf
et al. 2008). Very few of these studies
were proper randomized-controlled clin-
ical trials (Froum et al. 2002, Raghoebar
et al. 2005, Thor et al. 2005, 2007,
Consolo et al. 2007, Galindo-Moreno
et al. 2007, Plachokova et al. 2008).
Four of these authors used a split-mouth
design to evaluate the bone regeneration
in sinus floor elevation using PRP as
the unique variable. Raghoebar observed,
in a split-mouth study on sinus floor
elevations, that bone augmentation with
autogenous grafts did not increase signif-
icantly on adding PRP (41.1% at the non-
PRP group and 38.4% at the PRP group)
(Raghoebar et al. 2005).
Thor et al. (2007) observed a con-
spicuous increase in new bone forma-
tion obtained by combining PRP with an
autogenous bone during early healing
stages (3 months). Moreover, Consolo
et al. (2007) suggest certain regenerative
potential of PRP when used with an
autologous bone but no statistical differ-
ences were observed between sites trea-
ted or not treated with PRP.
Hence, these results confirm the
absence of consensus regarding the use-
fulness of combining autogenous bone
with PRP; the same conflicting results
appear when PRP is Q24added to ABB. For
instance, Froum et al. (2002) did not
observe any benefit from combining
PRP with ABB in three bilateral human
sinus floor elevation procedures. Galin-
do-Moreno et al. (2007) using a compo-
site graft of cortical autogenous bone,
bovine bone and PRP in sinus floor
elevations in humans, observed 34 "
6% new bone formation and indicated
its use as a successful bone graft mixture
for sinus augmentation, although the
absence of a control group in this study
prevents an objective evaluation of the
positive effect of PRP.
In our study, the clinical outcome of
bone regeneration procedures and the
dental implant replacement was not
influenced by the addition of PRP to
the bone substitute materials. The histo-
morphometric analysis revealed that the
sinuses grafted with ABB alone had
approximately the same percentage of
augmented bone volume as that reported
in similar studies (Tadjoedin and collea-
gues). We observed a percentage of new
bone formation of 21.3 " 4.5% while
Tadjoedin et al. (2003) reported 22.9 "
2.5% for the same conditions. However,
the sinuses grafted with ABB1PRP had
significantly higher amounts of bone
volume. Interestingly, the amount of
bone volume Q26obtained by combining
ABB with PRP (31 " 5%) was similar
to that reported by other authors for
composite grafts combining autogenous
bone with ABB in a 1:1 ratio (30.4 "
2.8%) Q27(Tadjoedin et al. 2003, Galindo-
Moreno et al. 2007).
The increased bone regeneration rates
observed with PRP were attributed to
the growth factor released from plate-
lets, as well as the fibrin network present
in PRP that is believed to enhance
Fig. 13. Image of patient 5 of Table 7. Bone
formation occurred in the apical part of the
biopsy in both groups (a) PRP1ABB and (b)
ABB alone. Although new bone formation
(NB) was observed in both groups, even in
the most apical part of the biopsies, more new
bone appears in the PRP1ABB group. We
also observed a decrease in the number of
bone bridges between ABB particles (RG,
residual graft) compared with the coronal part
of biopsies in the two groups (original mag-
nification $ 10). ABB, anorganic bovine
bone; PRP, platelet-rich plasma.
Fig. 14. Histomorphometric analysis of
maxillar sinuses 6 months after initial inter-
vention in the patients included for the split-
mouth clinical trial. NB, new bone; RG,
residual graft; CT, connective tissue.
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osteoconduction of the bone substitute
material (Marx et al. 1998). Although
some authors suggest that PRP induces
higher graft resorption rates in autolo-
gous bone grafts (Fennis et al. 2004,
Wiltfang et al. 2004), in this study,
PRP did not show any effect on the
resorption of the ABB particles. More-
over, the type of bone graft did not
influence either implant survival or
treatment success.
There are several reports associating
smoking with dental implant failure
(Chuang et al. 2002, Schwartz-Arad
et al. 2002). Tobacco contains several
noxious substances, resulting in vaso-
constriction and decreased tissue perfu-
sion, which produces pathological
ischaemia impairing wound healing. In
this study, implant survival and treat-
ment success was significantly lower in
smoking patients than in non-smokers,
smoking thus being an important risk
factor in sinus augmentation procedures.
This finding confirms previous reports
that associate smoking habits with fail-
ure of implants placed in augmented
sinuses (Olson et al. 2000, Kan et al.
2002, Schwartz-Arad et al. 2002).
The implant survival in augmented
maxillary sinuses observed in this study
was significantly higher in patients with
higher amounts of residual bone height.
This result is in agreement with previous
studies (Geurs et al. 2001). On the other
hand, the prevalence of membrane perfora-
tion observed was similar to that reported
by other authors (5.74%) (Pjetursson et al.
2008, Tonetti & Ha¨mmerle 2008). Further-
more, the lateral wall of the maxilla was
not covered with any membrane after graft
placement, and this did not affect the final
outcome of the treatments.
Conclusions
PRP is not a determining factor for
implant survival in sinus lifting proce-
dures. However, this study revealed that
PRP could improve the osteoconductive
properties of ABB by increasing the
volume of new bone formed, and also
the handling properties of bone substi-
tute particles. Moreover, in sinus aug-
mentation procedures implant survival
rate appears to be more influenced by
the residual bone height or by tobacco
than by the type of bone graft.
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Clinical Relevance
Scientific rationale for the study:
Although platelets are a natural
source of growth factors with bene-
ficial effects on tissue healing, the
use of PRP in bone regeneration is a
moot question. In this study, we
compare the bone augmentation
capacity of ABB alone and ABB
combined with PRP in sinus floor
elevation procedures.
Principal findings: PRP can improve
the osteoconductive properties of
ABB by increasing the bone volume
inside the sinuses even though this
does not affect the final success of
the treatment. On the contrary, resi-
dual bone height and smoking beha-
viour are relevant factors for
treatment success.
Practical implications: PRP is not a
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handling and the osteoconductive
properties of the graft in sinus aug-
mentation procedures.
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